The oral rehydration solution market is growing as governments, healthcare organizations, and consumers increase focus on hydration, diarrheal disease management, and preventive care. The market was valued at USD 5.87 billion in 2024 and is projected to reach USD 9.56 billion by 2035, growing at a CAGR of 4.53%.

ORS products are formulated with electrolytes, glucose, and water in proportions designed to support oral rehydration. They are widely used in public-health settings, hospitals, clinics, pharmacies, households, emergency programs, and travel-related care.

Diarrhea treatment is the largest application segment, accounting for around 42% of demand. This reflects the importance of hydration support during gastrointestinal illness. Children represent the largest end-user group because dehydration may develop quickly in young patients.

Powdered ORS leads the market because sachets are portable, cost-effective, easy to store, and widely used in community-health programs. Liquid formulations are growing quickly because they are ready to use and convenient for parents, elderly consumers, and travelers.

Public-health campaigns are central to market growth. Educational programs can help families recognize dehydration signs and understand the importance of safe fluid replacement. Access to affordable ORS products may be especially important in rural areas, disaster settings, and low-resource communities.

Read more: Oral Rehydration Solution Market 1064

FAQs

Q1. What is ORS used for?
It is used to support fluid and electrolyte replacement during dehydration.

Q2. Which ORS formulation leads the market?
Powdered formulations lead because they are portable, affordable, and easy to distribute.

Tags: oral rehydration solution, ORS market, dehydration management, pediatric hydration, public health